semaglutide and atrial fibrillation Atrial Fibrillation and Semaglutide Effects in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Program

Popular weight loss and anti-inflammatory drugs may help prevent common heart rhythm disorder A new BGU-led study published in Europace found that the GLP-1 drug semaglutide and the anti-inflammatory drug colchicine may

24.86

★★★★☆4.8 (126)

In a 68-year-old obese male (BMI ~36) with a history of atrial fibrillation controlled by two ablations, a permanent pacemaker, a Watchman left‑atrial appendage closure device, chronic obstructive pulmonary disease, and chronic

20.81

★★★★★4.9 (98)

Impact of GLP-1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis

24.34

★★★★★5.0 (157)

Abstract 4368472: Glucagon-Like Peptide 1 Mediated Reduction in Atrial Fibrillation Risk Is Independent of Weight Loss

23.35

★★★★★4.7 (84)

Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6

22.17

★★★★★4.9 (203)

Can Weight Loss Injections Cause Heart Problems? Safety Evidence

25.44

★★★★★5.0 (176)

Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation | Cardiovascular Diabetology

23.44

★★★★★4.8 (132)